← Eichor
Condition: Anger Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Anger

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Art Therapy and Emotional Well Being in Military Populations With Posttraumatic Stress Symptoms
NA · 2 location(s) · Walter Reed National Military Medical Center · NCT05414708
A Study Investigating the Safety, Absorption, Elimination, and the Effect on the Immune System of ACI-19764 in Healthy P
Phase 1 · 1 location(s) · AC Immune SA · NCT07463196
Predictive Factors for Occlusal Changes in Obstructive Sleep Apnea Treatment With Mandibular Advancement Appliance
Phase N/A · 1 location(s) · University Hospital, Toulouse · NCT06576310
Treatment of Chronic Anger and Aggression Following Military-Related Betrayal
NA · 1 location(s) · The University of Texas Health Science Center at San Antonio · NCT06609330
Fluoxetine on Emotional Experience (FLEX) Study
NA · 1 location(s) · University of Oxford · NCT07424781
A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020
Phase 1 · 1 location(s) · Luye Pharma Group Ltd. · NCT07230652
Therapy Dog Visits for Patients Hospitalized With Traumatic Injuries
NA · 1 location(s) · Boston Medical Center · NCT06812247
Phase I Study of XTL6001 Injection in Healthy and Obese Subjects
Phase 1 · 1 location(s) · Shanghai Xitaili Biomedicine Technology co., Ltd. · NCT07205432
Loop Recorder Implantation in Patients With Mitral Annular Disjunction
NA · 1 location(s) · Gottsegen National Cardiovascular Institute · NCT07436962
A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986521 in Healthy Participants.
Phase 1 · 1 location(s) · Bristol-Myers Squibb · NCT07283263
A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients.
Phase 1 · 18 location(s) · Mission Therapeutics · NCT07630545
Impact of Optimized Recruitment and Follow-up of Patients With Pseudoxanthoma Elasticum (PXE)
Phase N/A · 1 location(s) · University Hospital, Angers · NCT06636344
Step-by-Step: Evaluation of a Stepped Care Model
NA · 1 location(s) · Karolinska Institutet · NCT06902649
Parent Management Training to Treat Irritability
NA · 1 location(s) · University of Colorado, Denver · NCT06020261
First-in-Human Single and Multiple Dose of HL-400
Phase 1 · 1 location(s) · Highlightll Pharmaceutical (USA) LLC · NCT06997484
Mobile Anger Reduction Intervention
NA · 1 location(s) · VA Office of Research and Development · NCT06094933
A Phase 1, SAD and MAD Study to Evaluate the Safety and Tolerability of FB418
Phase 1 · 1 location(s) · 1ST Biotherapeutics, Inc. · NCT05995782
Phase 1 Trial of KH617
Phase 1 · 1 location(s) · Sichuan Honghe Biotechnology Co., Ltd. · NCT05667194
MAD Trial: Myopia Atropine Dose
Phase 3 · 20 location(s) · Erasmus Medical Center · NCT05667454
Long-term Benefits of CPAP or MAD Treatment on the Sleep of OSAS Patients
Phase N/A · 9 location(s) · ResMed · NCT05435794
IOA Preventing Occlusal Changes With MAD Use
NA · 1 location(s) · Isabel Moreno Hay · NCT07103941
CPAP vs MAD for OSA in Patients With Cognitive Impairment. A Randomized Clinical Trial
NA · 1 location(s) · National University Hospital, Singapore · NCT06983769
A Phase 1 Study of CLYM116 in Normal Healthy Volunteers
Phase 1 · 1 location(s) · Climb Bio, Inc. · NCT07248865
Building Emotional Awareness and Mental Health (BEAM) 2024-2027
NA · 1 location(s) · Leslie E. Roos · NCT06455397
A Study to Evaluate Safety and Pharmacokinetics of ZB002 in Healthy Participants and Participants With Rheumatoid Arthri
Phase 1 · 2 location(s) · Zenas BioPharma (USA), LLC · NCT05638854
Safety, Tolerability, and Pharmacokinetics of ASCT-83 in Healthy Adults
Phase 1 · 1 location(s) · Alcamena Stem Cell Therapeutics · NCT07363395
MAD Study of IA-14069
Phase 1 · 1 location(s) · ILAb Co., Ltd. · NCT05533372
A Mixed Methods Pilot Trial of the STEP Home Workshop to Improve Reintegration and Reduce Suicide Risk for Recently Tran
NA · 1 location(s) · VA Office of Research and Development · NCT05995678
MAD Study to Assess the Safety, Tolerability, PKs and Efficacy of YJ001 for Spray Use in Patients With DPNP
Phase 1 · 1 location(s) · Zhejiang Hanmai Pharmaceutical Technology Co., Ltd. · NCT06361108
A First-in-Human SAD/MAD Study to Evaluate Safety, Tolerability and PK of ENC0653 Ointment in Healthy Adult Subjects
Phase 1 · 1 location(s) · EnnovaBio · NCT07684196
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.